Mark Rapoport
Impact in
- Physiology top 5%
- Alzheimer's disease research and treatments
-
- Neuroscience and Neuropharmacology Research
- Nuclear Receptors and Signaling
Papers in
-
- Ocular Oncology and Treatments 4
-
- Cholinesterase and Neurodegenerative Diseases 2
- Co-authors
- Adriana Ferreira (3 shared papers)Michael P. Vitek (1 shared paper)Lester I. Binder (1 shared paper)Hana N. Dawson (1 shared paper)Mahmood F. Mafee (5 shared papers)Jian Feng (1 shared paper)Paul Greengard (1 shared paper)Hung‐Teh Kao (1 shared paper)
- Journals
- Neuroimaging Clinics of North America (3 papers)Magnetic Resonance Imaging Clinics of North America (1 paper)Radiologic Clinics of North America (1 paper)Journal of Neuroscience (1 paper)Journal of Neurochemistry (1 paper)
- Partner nations
- United States
In The Last Decade
Mark Rapoport
8 papers receiving 952 citations
Mark Rapoport's Hit Papers
Peers
Comparison fields: 5 of 75
- Physiology 657
- Cellular and Molecular Neuroscience 340
- Neurology 136
- Biological Psychiatry 32
- Pharmacology 212
Countries citing papers authored by Mark Rapoport
This map shows the geographic impact of Mark Rapoport's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Rapoport with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Rapoport more than expected).
Fields of papers citing papers by Mark Rapoport
This network shows the impact of papers produced by Mark Rapoport. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Rapoport. The network helps show where Mark Rapoport may publish in the future.
Co-authors
The 14 scholars most cited alongside Mark Rapoport, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Tau is essential to β-amyloid-induced neurotoxicity Hit paper breakdown → | 2002 | 651 |
| 2 | 2000 | 119 | |
| 3 | 2000 | 95 | |
| 4 | 2005 | 29 | |
| 5 | 2005 | 28 | |
| 6 | 2005 | 24 | |
| 7 | 2006 | 16 | |
| 8 | 2006 | 11 |
About Mark Rapoport
Mark Rapoport is a scholar working on Ophthalmology, Pharmacology, Cellular and Molecular Neuroscience, Neurology and Epidemiology, having authored 8 papers that have together received 973 indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (4 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Meningioma and schwannoma management (2 papers), Alzheimer's disease research and treatments (2 papers), Cerebral Venous Sinus Thrombosis (2 papers), Bone Tumor Diagnosis and Treatments (2 papers), Soft tissue tumor case studies (1 paper) and Vascular Malformations Diagnosis and Treatment (1 paper). The work is most often cited by research in Physiology (657 citations), Cellular and Molecular Neuroscience (340 citations), Neurology (136 citations), Biological Psychiatry (32 citations) and Pharmacology (212 citations). Mark Rapoport has collaborated with scholars based in United States. Frequent co-authors include Adriana Ferreira, Michael P. Vitek, Lester I. Binder, Hana N. Dawson, Mahmood F. Mafee, Jian Feng, Paul Greengard, Hung‐Teh Kao, Sameer A. Ansari and Afshin Karimi. Their work appears in journals such as Neuroimaging Clinics of North America, Magnetic Resonance Imaging Clinics of North America, Radiologic Clinics of North America, Journal of Neuroscience and Journal of Neurochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.